Cargando…
Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery
PURPOSE: In this study, we investigated the role of neutrophil to lymphocyte ratio (NLR) as a predictor of tumor response and as a prognostic factor in patients with rectal cancer who had undergone curative surgery after neoadjuvant chemoradiation therapy (nCRT). METHODS: Between January 2009 and Ju...
Autores principales: | Jeon, Byong Ho, Shin, Ui Sup, Moon, Sun Mi, Choi, Jung Il, Kim, Mi-Sook, Kim, Kie Hwan, Sung, Se-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Coloproctology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529757/ https://www.ncbi.nlm.nih.gov/pubmed/31113175 http://dx.doi.org/10.3393/ac.2018.10.01 |
Ejemplares similares
-
Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer
por: Kim, Ik Yong, et al.
Publicado: (2014) -
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
por: Dudani, Shaan, et al.
Publicado: (2019) -
Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation
por: Shen, Lijun, et al.
Publicado: (2014) -
Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study
por: Novin, Kambiz, et al.
Publicado: (2023) -
Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
por: Liu, Maoxi, et al.
Publicado: (2022)